Cell-free DNA: Preanalytical variables.

[1]  Mario Pazzagli,et al.  Influence of storage conditions and extraction methods on the quantity and quality of circulating cell-free DNA (ccfDNA): the SPIDIA-DNAplas External Quality Assessment experience , 2015, Clinical chemistry and laboratory medicine.

[2]  Dmitri D. Pervouchine,et al.  The human transcriptome across tissues and individuals , 2015, Science.

[3]  V. Wong,et al.  Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients , 2015, Proceedings of the National Academy of Sciences.

[4]  Alain R. Thierry,et al.  Pre-analytical Requirements for Analyzing Nucleic Acids from Blood , 2015 .

[5]  A. Farmer,et al.  Mood‐stabilizers differentially affect housekeeping gene expression in human cells , 2014, International journal of methods in psychiatric research.

[6]  F. Mouliere,et al.  Circulating cell free DNA: Preanalytical considerations. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[7]  S. Ju,et al.  Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer. , 2013, Clinical biochemistry.

[8]  Y. Lo,et al.  Clinical applications of maternal plasma fetal DNA analysis: translating the fruits of 15 years of research. , 2013, Clinical chemistry and laboratory medicine.

[9]  A. Hidalgo-Miranda,et al.  Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo Model , 2012, PloS one.

[10]  J. Egea-Guerrero,et al.  Role of early cell-free DNA levels decrease as a predictive marker of fatal outcome after severe traumatic brain injury. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[11]  P. Simon,et al.  Circulating Cell-Free DNA , 2012, Sports Medicine.

[12]  P. Gahan.  Biology of circulating nucleic acids and possible roles in diagnosis and treatment in diabetes and cancer. , 2012, Infectious disorders drug targets.

[13]  C. Dive,et al.  A Pilot Study Assessing the Prognostic Value of CK18 and nDNA Biomarkers in Severe Sepsis Patients , 2012, Clinical Drug Investigation.

[14]  D. Cook,et al.  Prognostic utility and characterization of cell-free DNA in patients with severe sepsis , 2012, Critical Care.

[15]  Man Yu,et al.  Cell-free circulating mitochondrial DNA in the serum: a potential non-invasive biomarker for Ewing's sarcoma. , 2012, Archives of medical research.

[16]  R. Stokowski,et al.  Influence of Temperature during Transportation on Cell-Free DNA Analysis , 2012, Fetal Diagnosis and Therapy.

[17]  V. de Giorgi,et al.  Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[18]  S. Holdenrieder,et al.  Methods for isolation of cell-free plasma DNA strongly affect DNA yield. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[19]  Klaus Pantel,et al.  Cell-free nucleic acids as biomarkers in cancer patients , 2011, Nature Reviews Cancer.

[20]  Tapio Kotipelto,et al.  Aging is associated with quantitative and qualitative changes in circulating cell-free DNA: The Vitality 90+ study , 2011, Mechanisms of Ageing and Development.

[21]  Yama W. L. Zheng,et al.  Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus , 2010, Science Translational Medicine.

[22]  K. Jung,et al.  Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[23]  M. Ychou,et al.  Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts , 2010, Nucleic acids research.

[24]  S. Norton,et al.  A new methodology to preserve the original proportion and integrity of cell‐free fetal DNA in maternal plasma during sample processing and storage , 2010, Prenatal diagnosis.

[25]  J. García-Verdugo,et al.  Molecular and Cellular Pathobiology Cancer Research Cell-Free Nucleic Acids Circulating in the Plasma of Colorectal Cancer Patients Induce the Oncogenic Transformation of Susceptible Cultured Cells , 2010 .

[26]  P. J. Pretorius,et al.  Is the role of circulating DNA as a biomarker of cancer being prematurely overrated? , 2010, Clinical biochemistry.

[27]  I. Holen,et al.  Optimizing the yield and utility of circulating cell-free DNA from plasma and serum. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[28]  M. Paci,et al.  Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer. , 2009, Lung cancer.

[29]  M. Ranson,et al.  Isolation and Extraction of Circulating Tumor DNA from Patients with Small Cell Lung Cancer , 2008, Annals of the New York Academy of Sciences.

[30]  M. Fleischhacker,et al.  An Improved Method for the Isolation of Free‐Circulating Plasma DNA and Cell‐Free DNA from Other Body Fluids , 2008, Annals of the New York Academy of Sciences.

[31]  A. Harris,et al.  Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.

[32]  E. Ruokonen,et al.  Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. , 2008, Clinical chemistry.

[33]  F. Crea,et al.  Workshop report on the extraction of foetal DNA from maternal plasma , 2007, Prenatal diagnosis.

[34]  Vishnu Swarup,et al.  Circulating (cell‐free) nucleic acids – A promising, non‐invasive tool for early detection of several human diseases , 2007, FEBS letters.

[35]  T. Anchordoquy,et al.  Metal contaminants promote degradation of lipid/DNA complexes during lyophilization. , 2007, Biochimica et biophysica acta.

[36]  M. Dziegiel,et al.  Improvement in fetal DNA extraction from maternal plasma. Evaluation of the NucliSens Magnetic Extraction system and the QIAamp DSP Virus Kit in comparison with the QIAamp DNA Blood Mini Kit , 2007, Prenatal diagnosis.

[37]  P. Pernet,et al.  Specific real-time PCR vs. fluorescent dyes for serum free DNA quantification , 2007, Clinical chemistry and laboratory medicine.

[38]  M. Fleischhacker,et al.  Circulating nucleic acids (CNAs) and cancer--a survey. , 2007, Biochimica et biophysica acta.

[39]  Jicun Ren,et al.  Comparisons between capillary zone electrophoresis and real-time PCR for quantification of circulating DNA levels in human sera. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[40]  R. Peñafiel,et al.  Protecting or promoting effects of spermine on DNA strand breakage induced by iron or copper ions as a function of metal concentration. , 2005, Journal of inorganic biochemistry.

[41]  K. C. Chan,et al.  Effects of preanalytical factors on the molecular size of cell-free DNA in blood. , 2005, Clinical chemistry.

[42]  D. Pisetsky,et al.  The effect of inflammation on the generation of plasma DNA from dead and dying cells in the peritoneum , 2005, Journal of leukocyte biology.

[43]  F. Naftolin,et al.  Circulation DNA: biological implications for cancer metastasis and immunology. , 2005, Medical hypotheses.

[44]  T. Godfrey,et al.  Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies. , 2005, Clinical chemistry.

[45]  Walter Weder,et al.  Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  H. Tschan,et al.  Increased concentrations of cell-free plasma DNA after exhaustive exercise. , 2004, Clinical chemistry.

[47]  O. Landt,et al.  Transrenal DNA as a Diagnostic Tool: Important Technical Notes , 2004, Annals of the New York Academy of Sciences.

[48]  T. Okai,et al.  Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low‐risk nonsymptomatic patients , 2004, Prenatal diagnosis.

[49]  R. Chiu,et al.  EDTA is a better anticoagulant than heparin or citrate for delayed blood processing for plasma DNA analysis. , 2004, Clinical chemistry.

[50]  U. Pastorino,et al.  Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer , 2003 .

[51]  M. Gaub,et al.  Plasma DNA microsatellite panel as sensitive and tumor‐specific marker in lung cancer patients , 2003, International journal of cancer.

[52]  K. Jung,et al.  Changes in concentration of DNA in serum and plasma during storage of blood samples. , 2003, Clinical chemistry.

[53]  D. Swinkels,et al.  Effects of blood-processing protocols on cell-free DNA quantification in plasma. , 2003, Clinical chemistry.

[54]  R. Stahel,et al.  Circulating DNA: a new diagnostic gold mine? , 2002, Cancer treatment reviews.

[55]  James T. Wu,et al.  Cell-free DNA: measurement in various carcinomas and establishment of normal reference range. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[56]  C. Lam,et al.  Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. , 2002, Clinical chemistry.

[57]  T. Okai,et al.  Increased cell-free fetal DNA in plasma of two women with invasive placenta. , 2002, Clinical chemistry.

[58]  T. Okai,et al.  Cell-free fetal DNA is increased in plasma of women with hyperemesis gravidarum. , 2001, Clinical chemistry.

[59]  L. Poon,et al.  Clinical Chemistry 47:9 1607–1613 (2001) Molecular Diagnostics and Genetics Effects of Blood-Processing Protocols on Fetal and Total DNA Quantification in Maternal Plasma , 2001 .

[60]  L. Mariani,et al.  Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. , 2001, Cancer research.

[61]  C. Hack,et al.  Cell-derived Microparticles Circulate in Healthy Humans and Support Low Grade Thrombin Generation , 2001, Thrombosis and Haemostasis.

[62]  M. Busch,et al.  Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma , 2001, Transfusion.

[63]  W. Holzgreve,et al.  Fluctuation of Maternal and Fetal Free Extracellular Circulatory DNA in Maternal Plasma , 2000, Obstetrics and gynecology.

[64]  L. Poon,et al.  Prenatal detection of fetal Down's syndrome from maternal plasma , 2000, The Lancet.

[65]  C. Oudejans,et al.  Detection of apoptotic fetal cells in plasma of pregnant women. , 2000, Clinical chemistry.

[66]  J. Jen,et al.  An Overview on the Isolation and Analysis of Circulating Tumor DNA in Plasma and Serum , 2000, Annals of the New York Academy of Sciences.

[67]  P. Laurent-Puig,et al.  Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. , 2000, Cancer research.

[68]  C. Gaillard,et al.  Eliminating DNA loss and denaturation during storage in plastic microtubes , 2000 .

[69]  D. Swinkels,et al.  Use of real-time quantitative PCR to compare DNA isolation methods. , 1998, Clinical chemistry.

[70]  C. Gaillard,et al.  Avoiding adsorption of DNA to polypropylene tubes and denaturation of short DNA fragments. , 1998 .

[71]  B. P. Belotserkovskii,et al.  Denaturation and association of DNA sequences by certain polypropylene surfaces. , 1997, Analytical biochemistry.

[72]  José Costa,et al.  PicoGreen quantitation of DNA: effective evaluation of samples pre- or post-PCR , 1996, Nucleic Acids Res..

[73]  B. P. Belotserkovskii,et al.  Polypropylene Tube Surfaces May Induce Denaturation and Multimerization of DNA , 1996, Science.

[74]  C. Gaillard,et al.  Association of poly(CA).poly(TG) DNA fragments into four-stranded complexes bound by HMG1 and 2. , 1994, Science.

[75]  J. Pourrat,et al.  Plasma DNA as cell death marker in elderly patients. , 1993, Gerontology.

[76]  A. Maebo,et al.  [Plasma DNA level as a tumor marker in primary lung cancer]. , 1990, Nihon Kyobu Shikkan Gakkai zasshi.

[77]  E. Beutler,et al.  Interference of heparin with the polymerase chain reaction. , 1990, BioTechniques.

[78]  B. Gordon,et al.  Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[79]  M. Stroun,et al.  Neoplastic characteristics of the DNA found in the plasma of cancer patients. , 1989, Oncology.

[80]  O. Avery,et al.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES , 1944, The Journal of experimental medicine.

[81]  B. Shapiro,et al.  Free DNA in the serum of cancer patients and the effect of therapy. , 1977, Cancer research.

[82]  R. Winchester,et al.  The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. , 1973, The Journal of clinical investigation.

[83]  P. Schur,et al.  Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. , 1966, The Journal of clinical investigation.

[84]  P Mandel,et al.  Les acides nucleiques du plasma sanguin chez l' homme , 1948 .

[85]  F. Griffith.  The Significance of Pneumococcal Types , 1928, Journal of Hygiene.